Small molecules discovered in a pathway screen target the Rho pathway in cytokinesis

被引:50
作者
Castoreno, Adam B. [1 ,2 ]
Smurnyy, Yegor [1 ,2 ]
Torres, Angelica D. [1 ,2 ]
Vokes, Martha S. [3 ]
Jones, Thouis R. [3 ]
Carpenter, Anne E. [3 ]
Eggert, Ulrike S. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[3] Broad Inst Harvard & MIT, Cambridge, MA USA
基金
美国国家卫生研究院;
关键词
CONTRACTILE RING; MYOSIN-II; GTPASES; ANILLIN; MICROTUBULES; PROTEIN; INHIBITOR; SPINDLE; KINASE; ACTIN;
D O I
10.1038/nchembio.363
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
We report the discovery of small molecules that target the Rho pathway, which is a central regulator of cytokinesis-the final step in cell division. We have developed a way of targeting a small molecule screen toward a specific pathway, which should be widely applicable to the investigation of any signaling pathway. In a chemical genetic variant of a classical modifier screen, we used RNA interference (RNAi) to sensitize cells and identified small molecules that suppressed or enhanced the RNAi phenotype. We discovered promising candidate molecules, which we named Rhodblock 1-8, and we identified the target of Rhodblock 6 as Rho kinase. Several Rhodblocks inhibited one function of the Rho pathway in cells: the correct localization of phosphorylated myosin light chain during cytokinesis. Rhodblocks differentially perturb Rho pathway proteins in cells and can be used to dissect the mechanism of the Rho pathway during cytokinesis.
引用
收藏
页码:457 / 463
页数:7
相关论文
共 51 条
[1]
Rho GTPases:: potential candidates for anticancer therapy [J].
Aznar, S ;
Fernández-Valerón, P ;
Espina, C ;
Lacal, JC .
CANCER LETTERS, 2004, 206 (02) :181-191
[2]
Rho GTPases in human cancer:: an unresolved link to upstream and downstream transcriptional regulation [J].
Benitah, SA ;
Valerón, PF ;
van Aelst, L ;
Marshall, CJ ;
Lacal, JC .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2004, 1705 (02) :121-132
[3]
Targeting Rho and Rho-kinase in the treatment of cardiovascular disease [J].
Budzyn, K ;
Marley, PD ;
Sobey, CG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (02) :97-104
[4]
CellProfiler: image analysis software for identifying and quantifying cell phenotypes [J].
Carpenter, Anne E. ;
Jones, Thouis Ray ;
Lamprecht, Michael R. ;
Clarke, Colin ;
Kang, In Han ;
Friman, Ola ;
Guertin, David A. ;
Chang, Joo Han ;
Lindquist, Robert A. ;
Moffat, Jason ;
Golland, Polina ;
Sabatini, David M. .
GENOME BIOLOGY, 2006, 7 (10)
[5]
Interaction between Anillin and RacGAP50C connects the actomyosin contractile ring with spindle microtubules at the cell division site [J].
D'Avino, Pier Paolo ;
Takeda, Tetsuya ;
Capalbo, Luisa ;
Zhang, Wei ;
Lilley, Kathryn S. ;
Laue, Ernest D. ;
Glover, David M. .
JOURNAL OF CELL SCIENCE, 2008, 121 (08) :1151-1158
[7]
Rho Kinase's Role in Myosin Recruitment to the Equatorial Cortex of Mitotic Drosophila S2 Cells Is for Myosin Regulatory Light Chain Phosphorylation [J].
Dean, Sara O. ;
Spudich, James A. .
PLOS ONE, 2006, 1 (02)
[8]
Distinct pathways control recruitment and maintenance of myosin II at the cleavage furrow during cytokinesis [J].
Dean, SO ;
Rogers, SL ;
Stuurman, N ;
Vale, RD ;
Spudich, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (38) :13473-13478
[9]
Rho GTPase expression in tumourigenesis:: evidence for a significant link [J].
del Pulgar, TG ;
Benitah, SA ;
Valerón, PF ;
Espina, C ;
Lacal, JC .
BIOESSAYS, 2005, 27 (06) :602-613
[10]
Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities [J].
Doe, Chris ;
Bentley, Ross ;
Behm, David J. ;
Lafferty, Robert ;
Stavenger, Robert ;
Jung, David ;
Bamford, Mark ;
Panchal, Terry ;
Grygielko, Eugene ;
Wright, Lois L. ;
Smith, Gary K. ;
Chen, Zunxuan ;
Webb, Christine ;
Khandekar, Sanjay ;
Yi, Tracey ;
Kirkpatrick, Robert ;
Dul, Edward ;
Jolivette, Larry ;
Marino, Joseph P. ;
Willette, Robert ;
Lee, Dennis ;
Hu, Erding .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (01) :89-98